Evidence map›Paper›PMID 35831316›Full record

ArticleNature communications2022

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.

Jasmin Bartl, Marco Zanini, Flavia Bernardi, Antoine Forget, Lena Blümel, Julie Talbot, Daniel Picard, Nan Qin, Gabriele Cancila, Qingsong Gao and 38 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 14 institutions in 8 countries.

Jasmin Bartl *Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany. jasmin.bartl@ini-research.org.ORCID 0000-0002-8737-2610
Marco Zanini *Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Flavia Bernardi *Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Antoine ForgetInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Lena BlümelDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Julie TalbotInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Daniel PicardDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Nan QinDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Gabriele CancilaInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Qingsong GaoSt Jude Children's Research Hospital, Memphis, TN, USA.
Soumav NathInstitut für Physikalische Biologie and Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany.
Idriss Mahoungou KoumbaDepartment of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.
Marietta WolterInstitute of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.
François KuonenProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Maike LanginiInstitute for Molecular Medicine, Proteome Research, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.ORCID 0000-0001-8622-3261
Thomas BeezDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Christopher MunozDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
David PauckDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Viktoria MarquardtDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Hua YuInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Judith SouphronInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.
Mascha KorschDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-1721-7754
Christina MöldersDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Daniel BergerDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Sarah GöbbelsDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Frauke-Dorothee MeyerDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Björn SchefflerDKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ), DKTK, partner site University Hospital Essen, Düsseldorf, Germany.ORCID 0000-0001-8316-6556
Barak RotblatDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Sven DiederichsDivision of Cancer Research, Department of Thoracic Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, DKTK, partner site Freiburg, Freiburg i.Br, Germany.ORCID 0000-0001-7901-4752
Vijay RamaswamyDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0002-6557-895X
Hiromishi SuzukiDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0002-8858-0294
Anthony OroProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-6261-138X
Kai StühlerMolecular Proteomics Laboratory (MPL), BMFZ, Heinrich Heine University, Düsseldorf, Germany.
Anja StefanskiMolecular Proteomics Laboratory (MPL), BMFZ, Heinrich Heine University, Düsseldorf, Germany.
Ute FischerDepartment of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-2455-2489
Gabriel LeprivierInstitute of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.
Dieter WillboldInstitut für Physikalische Biologie and Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany.
Gerhard StegerInstitut für Physikalische Biologie and Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany.
Alexander BuellDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0003-1161-3622
Marcel KoolHopp Children´s Cancer Center (KiTZ), Heidelberg, Germany.
Peter LichterDivision of Molecular Genetics, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Stefan M PfisterHopp Children´s Cancer Center (KiTZ), Heidelberg, Germany.ORCID 0000-0002-5447-5322
Paul A NorthcottSt Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-1220-5252
Michael D TaylorDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0001-7009-3466
Arndt BorkhardtDepartment of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, and DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-6121-4737
Guido ReifenbergerInstitute of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany, DKTK, partner site Essen/Düsseldorf, Düsseldorf, Germany.
Olivier AyraultInstitut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France. olivier.ayrault@curie.fr.ORCID 0000-0002-7942-6674
Marc RemkeDivision of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany. marc.remke@med.uni-duesseldorf.de.ORCID 0000-0002-9404-9993
German Cancer Research Center · DEHeinrich Heine University Düsseldorf · DEUniversité Paris-Sud · FRForschungszentrum Jülich · DEHospital for Sick Children · CASt. Jude Children's Research Hospital · USBen-Gurion University of the Negev · ILDüsseldorf University Hospital · DEHôpital de Beaumont · CHStanford University · USTechnical University of Denmark · DKUniversität Hamburg · DEUniversity of Freiburg · DEUniversity of Toronto · CA

Funding

REGULATING GLI FUNCTION IN HAIR FOLLICLE PROGENITORSR01AR054780 · NIAMS · STANFORD UNIVERSITY · PI ORO, ANTHONY E · 2007 to 2017
$4.3M
NIAMS NIH HHS R01 AR054780
6 · The paper itself

Abstract

Most lncRNAs display species-specific expression patterns suggesting that animal models of cancer may only incompletely recapitulate the regulatory crosstalk between lncRNAs and oncogenic pathways in humans. Among these pathways, Sonic Hedgehog (SHH) signaling is aberrantly activated in several human cancer entities. We unravel that aberrant expression of the primate-specific lncRNA HedgeHog Interacting Protein-AntiSense 1 (HHIP-AS1) is a hallmark of SHH-driven tumors including medulloblastoma and atypical teratoid/rhabdoid tumors. HHIP-AS1 is actively transcribed from a bidirectional promoter shared with SHH regulator HHIP. Knockdown of HHIP-AS1 induces mitotic spindle deregulation impairing tumorigenicity in vitro and in vivo. Mechanistically, HHIP-AS1 binds directly to the mRNA of cytoplasmic dynein 1 intermediate chain 2 (DYNC1I2) and attenuates its degradation by hsa-miR-425-5p. We uncover that neither HHIP-AS1 nor the corresponding regulatory element in DYNC1I2 are evolutionary conserved in mice. Taken together, we discover an lncRNA-mediated mechanism that enables the pro-mitotic effects of SHH pathway activation in human tumors.

Indexed as

Cerebellar NeoplasmsMedulloblastomaMicroRNAsRNA, Long NoncodingAnimalsCarrier ProteinsCell Line, TumorCell ProliferationDyneinsGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMembrane GlycoproteinsMiceCarrier ProteinsDyneinsHedgehog ProteinsHHIP protein, humanHhip protein, mouseMembrane GlycoproteinsMicroRNAsRNA, Long NoncodingSHH protein, humanShh protein, mouse

Identifiers

PMID35831316
PMCPMC9279496
OpenAlexW4285394570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.